Clinical Trials Browser

Phase 1/2 × NIH × Receptors, Chimeric Antigen × Clear all

NCT00924287 2015-10-28

Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer

Phase 1/2 Terminated

1 enrolled 8 charts

Neoplasm Metastasis, Neoplasms